147 related articles for article (PubMed ID: 28549350)
1. An anti-cancer WxxxE-containing azurin polypeptide inhibits Rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells.
Zhang Z; Luo Z; Min W; Zhang L; Wu Y; Hu X
Oncotarget; 2017 Jun; 8(26):43091-43103. PubMed ID: 28549350
[TBL] [Abstract][Full Text] [Related]
2. A small GTPase‑like protein fragment of Mycoplasma promotes tumor cell migration and proliferation in vitro via interaction with Rac1 and Stat3.
Hu X; Yu J; Zhou X; Li Z; Xia Y; Luo Z; Wu Y
Mol Med Rep; 2014 Jan; 9(1):173-9. PubMed ID: 24172987
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin I inhibits Rac1 activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of Janus tyrosine kinase 2 and P-Rex1.
Lopez-Haber C; Kazanietz MG
Mol Pharmacol; 2013 May; 83(5):1141-54. PubMed ID: 23478800
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
5. 6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1.
Marinković G; Hamers AA; de Vries CJ; de Waard V
Inflamm Bowel Dis; 2014 Sep; 20(9):1487-95. PubMed ID: 25029617
[TBL] [Abstract][Full Text] [Related]
6. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
8. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
[TBL] [Abstract][Full Text] [Related]
9. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.
Cardama GA; Comin MJ; Hornos L; Gonzalez N; Defelipe L; Turjanski AG; Alonso DF; Gomez DE; Menna PL
Anticancer Agents Med Chem; 2014; 14(6):840-51. PubMed ID: 24066799
[TBL] [Abstract][Full Text] [Related]
10. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway.
Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X
Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
12. A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo.
Catalano S; Leggio A; Barone I; De Marco R; Gelsomino L; Campana A; Malivindi R; Panza S; Giordano C; Liguori A; Bonofiglio D; Liguori A; Andò S
J Cell Mol Med; 2015 May; 19(5):1122-32. PubMed ID: 25721149
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
Hamamura K; Minami K; Tanjung N; Wan Q; Koizumi M; Matsuura N; Na S; Yokota H
Int J Oncol; 2014 Jun; 44(6):1980-8. PubMed ID: 24691491
[TBL] [Abstract][Full Text] [Related]
14. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
15. Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth.
Li X; Ma H; Li L; Chen Y; Sun X; Dong Z; Liu JY; Zhu W; Zhang JT
Oncogene; 2018 May; 37(18):2469-2480. PubMed ID: 29456240
[TBL] [Abstract][Full Text] [Related]
16. Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo.
Yue P; Lopez-Tapia F; Paladino D; Li Y; Chen CH; Namanja AT; Hilliard T; Chen Y; Tius MA; Turkson J
Cancer Res; 2016 Feb; 76(3):652-63. PubMed ID: 26088127
[TBL] [Abstract][Full Text] [Related]
17. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
[TBL] [Abstract][Full Text] [Related]
19. NGF-dependent formation of ruffles in PC12D cells required a different pathway from that for neurite outgrowth.
Jin E; Nosaka K; Sano M
Neurochem Int; 2007; 51(2-4):216-26. PubMed ID: 17561310
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
